...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM Content
Reply New Message
Back To Forum List View
AGM Content
3
Toinv
Oct 08, 2021 10:44AM

I fear you are correct jonzo.

I've let the hope that after 11 years invested in Zen/RVX I would finally make a buck or 2. I've let my mind get clouded by the false expectations set up by Don when he said...you'll be amazed how fast cancer trials move.

There probably won't be any money here until the investment bankers take over.

I guess it is nice to watch the science develop.

GLTA

Toinv

2 Recommendations
Re: AGM Content
5
Cottenmouth
Oct 14, 2021 07:13PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply